Five of the world's top 20 pharma and biotech companies use Diligent Pharma
The Diligent Qualification Platform (DQP) is designed to speed up and simplify the assessment of GCP/GCLP service and technology providers. We make it easier and faster for a sponsor to contract with, and identify and manage the risks associated with clinical trial service vendors.
With a growing number of users at both clinical trial sponsors and service providers, the DQP is fast becoming the go-to place for trial sponsors to find and onboard new service providers quickly. Currently five of the top 20 pharma and biotech companies worldwide subscribe to the Diligent Qualification Platform and we are in discussions with many more.
See how top pharma and biotech companies benefit with Diligent in our customer success stories
What this means for you:
If you are a clinical trial sponsor, the platform will help you streamline the selection and qualification of clinical trial service and technology providers.
You will drastically reduce the time and resources you currently use for vendor qualification and can mitigate trial risks more easily.
See our Benefits for Trial Sponsors
If you are a vendor of services or technologies that support clinical research, joining our Provider Community will allow you to reach sponsors more easily that are actively searching for the services that you offer. This will help you to secure more new business with less resources.
See our Benefits for Providers